Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report
Liam A Hilleary, Christopher Wratten, Shankar Siva, Jenna Hilleary, Jarad M Martin
BMC CANCER | BMC | Published : 2019
BACKGROUND: Stereotactic radiotherapy is an emerging treatment option for patients with inoperable renal cell carcinoma (RCC). Haemorrhage has not previously been reported to occur as a result of Stereotactic Body Radiotherapy (SBRT) to the kidney for primary RCC. We report an acute haemorrhage in a patient who received only one of three planned fractions of SBRT as part of a clinical trial. CASE PRESENTATION: A 74 year old female had a left renal mass under observation for 4 years, during which time she was imaged repeatedly using ultrasound and CT scans. There has been no evidence of metastases, and the lesion has demonstrated a steady pattern of growth over the 4-year period. Fine needle ..View full abstract
Awarded by Centre for Clinical Radiation Research at the University of Newcastle, University Drive, Callaghan New South Wales
If our manuscript is accepted into BMC Cancer, funding for costs relating to publication is to be provided by the:Centre for Clinical Radiation Research at the University of Newcastle, University Drive, Callaghan New South Wales 2308. Grant Number: 20171101.